Cargando…

Health outcomes and healthcare resource utilization among Veterans with stage IV non-small cell lung cancer treated with second-line chemotherapy versus immunotherapy

BACKGROUND: Until recently, multi-agent chemotherapy (CT) was the standard of care for patients with advanced non-small cell lung cancer (NSCLC). Clinical trials have confirmed benefits in overall survival (OS) and progression-free survival with immunotherapy (IO) compared to CT. This study compares...

Descripción completa

Detalles Bibliográficos
Autores principales:	Williams, Christina D., Allo, Mina A., Gu, Lin, Vashistha, Vishal, Press, Ashlyn, Kelley, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942992/ https://www.ncbi.nlm.nih.gov/pubmed/36809528 http://dx.doi.org/10.1371/journal.pone.0282020

Ejemplares similares

Disproportionate utilization of healthcare resources among veterans with COPD: a retrospective analysis of factors associated with COPD healthcare cost
por: Darnell, Kyle, et al.
Publicado: (2013)

Angina Severity, Mortality, and Healthcare Utilization Among Veterans With Stable Angina
por: Owlia, Mina, et al.
Publicado: (2019)

Women Veterans’ Healthcare Needs, Utilization, and Preferences in Veterans Affairs Primary Care Settings
por: Sheahan, Kate L., et al.
Publicado: (2022)

Efficacy of second-line chemotherapy after immunotherapy in advanced non-small cell lung cancer
por: Hirata, Tsuyoshi, et al.
Publicado: (2023)

Immunotherapy combined with rh-endostatin improved clinical outcomes over immunotherapy plus chemotherapy for second-line treatment of advanced NSCLC
por: Huang, Hongxiang, et al.
Publicado: (2023)

Medical oncologists’ perspectives of the Veterans Affairs National Precision Oncology Program
por: Vashistha, Vishal, et al.
Publicado: (2020)

555. Utilization of Remdesivir for COVID-19 in the National Veterans Affairs Healthcare System
por: Caffrey, Aisling, et al.
Publicado: (2021)

HEALTHCARE UTILIZATION FOR US VETERANS WITH HEART FAILURE DURING THE COVID19 PANDEMIC
por: Brownell, Nicholas Keisuke, et al.
Publicado: (2023)

Transgender Veterans and the Veterans Health Administration: Exploring the Experiences of Transgender Veterans in the Veterans Affairs Healthcare System
por: Rosentel, Kris, et al.
Publicado: (2016)

A Bayesian network analysis of immunotherapy and taxane chemotherapy as second- or later-line treatments in non-small cell lung cancer
por: Liu, Xin-Xiu, et al.
Publicado: (2022)

Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma
por: Eager, Robert M, et al.
Publicado: (2009)

COVID-19-Associated Mortality in US Veterans with and without SARS-CoV-2 Infection
por: Suzuki, Ayako, et al.
Publicado: (2021)

Successful conversion surgery for stage IV gastric cancer with liver metastases after second-line chemotherapy with ramucirumab and paclitaxel: a case report
por: Fukuda, Kosuke, et al.
Publicado: (2022)

Controversies in NSCLC: which second-line strategy after chemo-immunotherapy?
por: Moliner, L., et al.
Publicado: (2023)

PB2359: HEALTHCARE RESOURCE UTILIZATION OF ADULT PATIENTS WITH PYRUVATE KINASE DEFICIENCY: A REAL WORLD STUDY USING US VETERANS HEALTH ADMINISTRATION DATA
por: Zagadailov, E., et al.
Publicado: (2022)

First Line and Second Line Chemotherapy in Advanced Cholangiocarcinoma and Impact of Dose Reduction of Chemotherapy: A Retrospective Analysis
por: Möhring, Christian, et al.
Publicado: (2021)

Real-world effectiveness of second-line Afatinib versus chemotherapy for the treatment of advanced lung squamous cell carcinoma in immunotherapy-naïve patients
por: Chen, You-Yi, et al.
Publicado: (2021)

Cost-Effectiveness of Nivolumab Immunotherapy vs. Paclitaxel or Docetaxel Chemotherapy as Second-Line Therapy in Advanced Esophageal Squamous Cell Carcinoma in China
por: Lin, Ying-tao, et al.
Publicado: (2022)

Efficacy and safety of immunotherapy combined with single-agent chemotherapy as second- or later-line therapy for metastatic non-small cell lung cancer
por: Chen, Dongna, et al.
Publicado: (2023)

To Understand and Support Contemporary Veterans Utilizing Biblical Combat Veteran Types
por: Grimell, Jan
Publicado: (2018)

Impact of presumed service-connected diagnosis on the Department of Veterans Affairs healthcare utilization patterns of Vietnam-Theater Veterans: A cross-sectional study
por: Fried, Dennis A., et al.
Publicado: (2018)

811. Utilizing IV team in Reducing the Central Line Associated Infections
por: Srialluri, Swetha, et al.
Publicado: (2020)

Medications Associated with Lower Mortality in a SARS-CoV-2 Positive Cohort of 26,508 Veterans
por: Hunt, Christine M., et al.
Publicado: (2022)

Second-Line Chemotherapy for Intrahepatic Cholangiocarcinomas: What Is the Real Gain?
por: Garajová, Ingrid, et al.
Publicado: (2023)

Cost‐effectiveness of second‐line ipilimumab for metastatic melanoma: A real‐world population‐based cohort study of resource utilization
por: Lu, Brandon, et al.
Publicado: (2023)

Impact on healthcare resource utilization of multiple sclerosis in Spain
por: Sicras-Mainar, Antoni, et al.
Publicado: (2017)

Healthcare Resource Utilization for Chronic Rhinosinusitis in Older Adults
por: Jang, David W., et al.
Publicado: (2021)

Burden of Endometriosis: Infertility, Comorbidities, and Healthcare Resource Utilization
por: Eisenberg, Vered H., et al.
Publicado: (2022)

Health Experiences Research as a Resource and Mechanism for Veteran Engagement in VA Healthcare Research and Care Delivery
por: Nugent, Shannon M., et al.
Publicado: (2022)

Differences in COVID-19-Related Testing and Healthcare Utilization by Race and Ethnicity in the Veterans Health Administration
por: Razjouyan, Javad, et al.
Publicado: (2021)

Factors associated with early receipt of COVID-19 vaccination and adherence to second dose in the Veterans Affairs healthcare system
por: Ioannou, George N., et al.
Publicado: (2021)

Value of chemotherapy post immunotherapy in stage IV non-small cell lung cancer (NSCLC)
por: Assi, Hazem I., et al.
Publicado: (2023)

Estimating healthcare mobility in the Veterans Affairs Healthcare System
por: Wang, Karen H., et al.
Publicado: (2016)

Tele-Healthcare in Research and Education: Age Differences in Access and Utilization of Healthcare Resources
por: Hills, William, et al.
Publicado: (2021)

Tele-Healthcare in Research and Education: Age Differences in Access and Utilization of Healthcare Resources
por: Hills, William, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of Camrelizumab Immunotherapy versus Docetaxel or Irinotecan Chemotherapy as Second-Line Therapy for Advanced or Metastatic Esophageal Squamous Cell Carcinoma
por: Lin, Ying-Tao, et al.
Publicado: (2021)

Healthcare resource utilization trends in patients with acute myeloid leukemia ineligible for intensive chemotherapy receiving first‐line systemic treatment or best supportive care: A multicenter international study
por: Ito, Tomoki, et al.
Publicado: (2022)

Cost-Utility Analysis of Dapagliflozin Compared to Sulfonylureas for Type 2 Diabetes as Second-Line Treatment in Indian Healthcare Payer’s Perspective
por: Bagepally, Bhavani Shankara, et al.
Publicado: (2021)

Sexual Victimization, Health Status, and VA Healthcare Utilization Among Lesbian and Bisexual OEF/OIF Veterans
por: Mattocks, Kristin M., et al.
Publicado: (2013)

Do healthier lifestyles lead to less utilization of healthcare resources?
por: Lee, I-Chen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5pevq3kaj4pj25gnfhs3g4b5a3